[LOGO GOES HERE]

FOR IMMEDIATE RELEASE:                              CONTACT:

Valhi, Inc.                                         Bobby D. O'Brien
Three Lincoln Centre                                Vice President
5430 LBJ Freeway                                    (972) 233-1700
Suite, 1700
Dallas, Texas  75240-2697



                     VALHI REPORTS THIRD QUARTER RESULTS AND
                DELAY IN FILING ITS QUARTERLY REPORT ON FORM 10-Q


     DALLAS,  TEXAS . . November 14, 2005.  Valhi,  Inc.  (NYSE:  VHI)  reported
income from continuing  operations of $18.5 million,  or $.16 per diluted share,
in the third  quarter of 2005 compared to income of $16.3  million,  or $.14 per
diluted share,  in the third quarter of 2004. For the first nine months of 2005,
Valhi reported income from continuing  operations of $82.9 million,  or $.69 per
diluted share, compared to income of $298.1 million, or $2.48 per diluted share,
in the first nine months of 2004. The Company's  results in 2004 include certain
significant income tax benefits, as discussed below.

     Chemicals  sales  increased  $6.0  million  in the  third  quarter  of 2005
compared to the third quarter of 2004, and increased  $50.6 million in the first
nine  months of 2005,  due to the net  effects of higher  average  TiO2  selling
prices, lower TiO2 sales volumes as well as the favorable effect of fluctuations
in  foreign  currency  exchange  rates,  which  increased   chemicals  sales  by
approximately  $2 million  and $24  million in the third  quarter and first nine
month periods,  respectively.  Excluding the effect of fluctuations in the value
of the U.S.  dollar relative to other  currencies,  Kronos' average TiO2 selling
prices in  billing  currencies  in the third  quarter  of 2005 were 7% higher as
compared  to the third  quarter  of 2004,  and were 9% higher for the first nine
months of the year.  When  translated  from billing  currencies to U.S.  dollars
using actual foreign currency  exchange rates  prevailing  during the respective
periods, Kronos' average TiO2 selling prices in the third quarter and first nine
months of 2005 increased 8% and 12%, respectively,  compared to the same periods
of 2004.

     Kronos'  TiO2  sales  volumes in each of the third  quarter  and first nine
months of 2005  decreased  7% as  compared  to the same  periods  in 2004,  with
volumes lower in all regions of the world.  Kronos' operating income comparisons
were favorably impacted by higher production  levels,  which increased 2% in the
first nine months of 2005 as  compared  to the same  period in 2004.  Production
volumes in the third  quarter  of 2005 were 1% lower  than the third  quarter of
last year.  Kronos' operating rates were near full capacity in all periods,  and
Kronos'  production  volumes in the first nine  months of 2005 were a new record
for Kronos  for a first  nine-month  period.  Fluctuations  in foreign  currency
exchange rates resulted in  approximately a net $2 million increase in chemicals
operating   income  for  the  year-to-date   period   (currency   exchange  rate
fluctuations  did  not  have a  significant  effect  on  the  quarter-to-quarter
comparisons).  Chemicals  operating  income  in the  first  nine  months of 2004
includes $6.3 million of income ($3.5 million, or $.03 per diluted share, net of
income taxes and minority  interest)  in the second  quarter  related to Kronos'
settlement of a contract dispute with a customer.

     On September  22, 2005,  the  chloride-process  TiO2  facility  operated by
Kronos' 50%-owned joint venture, Louisiana Pigment Company ("LPC"),  temporarily
halted  production  due  to  Hurricane  Rita.  Although  storm  damage  to  core
processing facilities was not extensive, a variety of factors, including loss of
utilities,  limited  access,  and  availability  of employees and raw materials,
prevented the resumption of partial operations until October 9, 2005. Operations
are expected to be restored in early  November 2005. LPC expects the majority of
its damage and  unabsorbed  fixed costs for periods in which  normal  production
levels were not achieved are covered by insurance, and Kronos believes insurance
will cover its business interruption losses (subject to applicable  deductibles)
resulting from its share of the lost  production from LPC.  Chemicals  operating
income in the third quarter of 2005 includes  approximately  $1 million of costs
related to Hurricane Rita  (primarily  Kronos' share of LPC's  unabsorbed  fixed
costs) for which no insurance  recovery has yet been  recognized  as the amounts
are not presently  determinable.  The effect on the Company's  financial results
will  depend on the timing and amount of  insurance  recoveries.  Kronos'  owned
warehouse and slurry  facilities  located near LPC were also temporarily  closed
due to the storm, but property damage to these facilities was not significant.

     Component  products sales  increased in 2005 due primarily to sales volumes
associated  with a components  products  business  acquired in August 2005,  the
favorable  effect of  fluctuations  in currency  exchange rates and increases in
selling prices for certain  products  across all segments,  partially  offset by
lower  volumes  for  certain  products.   Component  products  operating  income
increased  in the first nine  months of 2005 as  compared  to the same period in
2004 as the  favorable  impact of a  continuous  focus on  reducing  costs  were
partially  offset by the  negative  impact of  foreign  currency  exchange  rate
fluctuations.  Waste management sales increased in the first nine months of 2005
as compared to the same period of 2004, but its operating  losses also increased
in the 2005  periods as higher  operating  costs more than  offset the effect of
higher utilization of certain waste management services.

     Effective  January 1, 2005,  TIMET  changed  its method of  accounting  for
approximately 40% of its inventories from the last-in, first-out ("LIFO") method
to the specific identification cost method,  representing all of its inventories
previously  accounted for under the LIFO method.  In accordance  with accounting
principles  generally  accepted in the United  States of America  ("GAAP"),  the
Company has  retroactively  restated its  consolidated  financial  statements to
reflect its results of operations as if TIMET had accounted for such inventories
under the new method  for all  periods  presented.  As a result,  the  Company's
income from continuing  operations in the third quarter and first nine months of
2004 is $239,000 and $804,000, respectively, higher than previously reported.

     TIMET's sales increased from $120.2 million in the third quarter of 2004 to
$190.0  million  in the third  quarter of 2005,  and  TIMET's  operating  income
increased  from  $13.4  million to $51.3  million.  The  improvement  in TIMET's
operating  results in 2005 was due in part to a 66% increase in average  selling
prices for melted  products  (ingot and slab),  a 35%  increase in mill  product
average  selling  prices,  a 9% increase in mill product sales volumes and a 14%
increase in melted product sales volumes.  TIMET's operating results comparisons
were also favorably  impacted by improved plant operating rates, which increased
from 72% in the third quarter of 2004 to 77% in the third  quarter of 2005,  and
higher gross margin from the sale of titanium scrap and other non-mill products.
In addition,  TIMET's operating results  comparisons were negatively impacted by
higher costs for raw materials. TIMET's results in the first nine months of 2005
include a second quarter  pre-tax gain of $13.9 million ($2.6  million,  or $.02
per diluted share,  net of income taxes and minority  interest to Valhi) related
to the sale of certain  real  property  adjacent to TIMET's  facility in Nevada.
TIMET's  results in the first nine months of 2005 also  include a $41.1  million
income tax benefit ($11.1  million,  or $.09 per diluted share,  net of minority
interest to Valhi) related to reversal of the valuation allowances  attributable
to TIMET's deferred income tax assets in the U.S. and U.K. Equity in earnings of
TIMET in the  third  quarter  of 2004  includes  income  of $6.3  million  ($4.1
million,  or  $.03  per  diluted  share,  net  of  income  taxes)  related  to a
nonoperating  gain recognized by TIMET upon the exchange of substantially all of
its  convertible  preferred debt  securities for a new issue of TIMET  preferred
stock.

     General  corporate  interest  and  dividend  income was higher in the third
quarter and first nine  months of 2005 as  compared to the same  periods of 2004
due  primarily  to a  higher  level  of  funds  available  for  investment.  Net
securities  transactions  gains in 2005 relate  principally  to (i) NL's sale of
shares of Kronos  common stock in market  transactions  of $14.7  million in the
first nine  months of 2005 ($6.6  million,  or $.05 per  diluted  share,  net of
income taxes and minority  interest) and (ii) a second quarter $5.4 million gain
($3.1  million,  or $.03 per diluted  share,  net of income  taxes and  minority
interest)  related  to  Kronos'  sale of its  passive  interest  in a  Norwegian
smelting operation.  Insurance  recoveries in 2005 include $1.2 million received
by NL from certain insolvent former insurance carriers relating to settlement of
excess insurance coverage claims received by NL. Interest expense was higher due
primarily to higher outstanding levels of debt at Kronos.

     The Company's  income tax expense in the third quarter of 2005 includes the
net  non-cash  effects  of  (i)  the  aggregate   favorable  effects  of  recent
developments  with  respect  to  certain  non-U.S.  income tax audits of Kronos,
principally in Belgium and Canada, of $12.5 million ($10.8 million,  or $.09 per
diluted share,  net of minority  interest),  (ii) the favorable effect of recent
developments  with  respect to certain  income tax items of NL of $10.8  million
($9.0 million, or $.08 per diluted share, net of minority  interest),  (iii) the
unfavorable  effect with respect to the loss of certain income tax attributes of
Kronos in Germany of $17.5 million  ($15.2  million,  or $.13 per diluted share,
net of minority  interest)  and (iv) the  unfavorable  effect with  respect to a
change in CompX's  permanent  reinvestment  conclusion  regarding  its  non-U.S.
subsidiaries  of $9.0 million ($5.1 million,  or $.04 per diluted share,  net of
minority interest).  As previously reported, the Company's income tax benefit in
the second  quarter of 2004 includes (i) a $268.6  million  non-cash  income tax
benefit ($230.2 million,  or $1.91 per diluted share, net of minority  interest)
related to the  reversal  of a deferred  income  tax asset  valuation  allowance
attributable  to Kronos'  income tax  attributes  in  Germany  (principally  net
operating  loss  carryforwards)  and (ii) a $43.7  million  non-cash  income tax
benefit ($36.4  million,  or $.30 per diluted share,  net of minority  interest)
related to income tax attributes of a subsidiary of NL.

     As  previously  reported,  in January 2005 CompX  completed the sale of its
Thomas Regout  operations in The  Netherlands,  and  accordingly  the results of
operations of Thomas Regout  (which  reported a nominal  amount of net income in
the third quarter and first nine months of 2004) are classified as  discontinued
operations  for all periods  presented.  Discontinued  operations in 2005 relate
primarily  to  additional  expenses  associated  with the disposal of the Thomas
Regout operations.

     As disclosed in the Company's Current Report on Form 8-K dated November 14,
2005 and filed with the  Securities  and Exchange  Commission,  the Company will
file an Annual  Report on Form  10-K/A for the year ended  December  31, 2004 to
restate its  consolidated  financial  statements for certain  matters more fully
described in such Form 8-K. The  Company's  results of  operations  for the 2004
interim periods,  as presented herein,  have been restated for the effect of one
of the matters discussed in such Form 8-K, resulting in a $1.1 million decrease,
or $.01 per diluted  share,  in net income for the three months ended  September
30, 2004 and a $1.6 million,  or $.01 per diluted share,  decrease in net income
for the nine months ended  September 30, 2004.  As more fully  described in such
Form 8-K,  such  amounts  relate  to  certain  income  taxes  which the  Company
previously accounted for as a direct reduction in its stockholders'  equity. The
aggregate effect of the restatement,  however, will be to increase the Company's
stockholders'  equity as of December 31, 2004.  As a result of the time involved
in  addressing  the matters  described  in such Form 8-K,  the  Company  will be
delayed  in filing  its  Quarterly  Report on Form  10-Q for the  quarter  ended
September 30, 2005,  which  Quarterly  Report would  otherwise be required to be
filed today.  While the Company  currently  believes the  financial  information
contained in this release will be  consistent  with the  Company's  consolidated
financial  statements that will be contained in its Quarterly Report when filed,
the  financial  information  contained in this release is,  however,  subject to
future correction and revision and could differ from the Company's  consolidated
financial statements that will be contained in its Quarterly Report when filed.

     The statements in this release  relating to matters that are not historical
facts are  forward-looking  statements that represent  management's  beliefs and
assumptions  based on  currently  available  information.  Although  the Company
believes that the expectations reflected in such forward-looking  statements are
reasonable,  it cannot give any assurances that these expectations will prove to
be correct.  Such  statements  by their  nature  involve  substantial  risks and
uncertainties  that could  significantly  impact  expected  results,  and actual
future   results  could  differ   materially   from  those   described  in  such
forward-looking  statements.  While it is not  possible to identify all factors,
the Company  continues to face many risks and  uncertainties.  Among the factors
that could cause actual future results to differ materially include, but are not
limited to:

     o    Future supply and demand for the Company's products,
     o    The extent of the dependence of certain of the Company's businesses on
          certain market sectors,
     o    The cyclicality of certain of the Company's businesses,
     o    The impact of certain long-term  contracts on certain of the Company's
          businesses,
     o    Customer inventory levels,
     o    Changes in raw material and other operating costs,
     o    The possibility of labor disruptions,
     o    General global economic and political conditions,
     o    Competitive products and substitute products,
     o    Customer and competitor strategies,
     o    The impact of pricing and production decisions,
     o    Competitive technology positions,
     o    The introduction of trade barriers,
     o    Fluctuations in currency exchange rates,
     o    Operating interruptions,
     o    The timing and amount of insurance recoveries,
     o    The ability of the Company to renew or refinance credit facilities,
     o    Uncertainties associated with new product development,
     o    The ultimate outcome of income tax audits, tax settlement  initiatives
          or other tax matters,
     o    The ultimate ability to utilize income tax attributes,  the benefit of
          which has been recognized under the "more-likely-than-not" recognition
          criteria,
     o    Environmental matters,
     o    Government laws and regulations and possible changes therein,
     o    The ultimate resolution of pending  litigation,  and o Possible future
          litigation.

Should one or more of these risks  materialize  (or the  consequences  of such a
development  worsen),  or should the  underlying  assumptions  prove  incorrect,
actual results could differ  materially from those  forecasted or expected.  The
Company   disclaims  any  intention  or  obligation  to  update  or  revise  any
forward-looking statement whether as a result of changes in information,  future
events or otherwise.

     In an effort to provide investors with additional information regarding the
Company's results of operations as determined by GAAP, the Company has disclosed
certain  non-GAAP   information  which  the  Company  believes  provides  useful
information to investors:

     o    The  Company  discloses  percentage  changes in Kronos'  average  TiO2
          selling  prices in billing  currencies,  which excludes the effects of
          foreign currency translation.  The Company believes disclosure of such
          percentage  changes allows  investors to analyze such changes  without
          the  impact of changes in foreign  currency  exchange  rates,  thereby
          facilitating  period-to-period  comparisons of the relative changes in
          average  selling  prices in the  actual  various  billing  currencies.
          Generally,  when the U.S. dollar either strengthens or weakens against
          other  currencies,  the percentage change in average selling prices in
          billing  currencies will be higher or lower,  respectively,  than such
          percentage  changes would be using actual  exchange  rates  prevailing
          during the respective periods.

     Valhi, Inc. is engaged in the titanium dioxide pigments, component products
(precision ball bearing slides, security products and ergonomic computer support
systems), titanium metals products and waste management industries.

                                    * * * * *






                          VALHI, INC. AND SUBSIDIARIES
                              SUMMARY OF OPERATIONS
                                   (Unaudited)
                    (In millions, except earnings per share)




                                                                              Three months ended             Nine months ended
                                                                                September 30,                  September 30,
                                                                           -----------------------        ----------------------
                                                                            2004            2005            2004           2005
                                                                           ------          ------         --------        ------
 Net sales
                                                                                                            
   Chemicals                                                               $286.1         $292.1          $ 845.1       $  895.7
   Component products                                                        46.3           47.1            136.1          139.7
   Waste management                                                           4.4            3.0              6.6            7.5
                                                                           ------         ------          -------       --------

                                                                           $336.8         $342.2          $ 987.8       $1,042.9
                                                                           ======         ======          =======       ========

 Operating income
   Chemicals                                                               $ 25.8         $ 35.5          $  84.2       $  134.2
   Component products                                                         4.9            4.9             12.5           13.8
   Waste management                                                           (.5)          (2.8)            (7.3)          (9.1)
                                                                           ------         ------          -------       --------

     Total operating income                                                  30.2           37.6             89.4          138.9

 Equity in:
   TIMET                                                                     11.5           15.0             14.9           47.6
   Other                                                                      2.4            2.6              2.5            2.4

 General corporate items:
   Interest and dividend income                                               8.5            9.4             25.4           28.9
   Securities transaction gains, net                                          -             -                 -             20.2
   Insurance recoveries                                                       -              1.2               .5            2.4
   Gain on disposal of fixed assets                                           -             -                  .6           -
   General expenses, net                                                     (6.1)          (7.2)           (21.6)         (23.1)
 Interest expense                                                           (15.2)         (16.7)           (45.9)         (52.4)
                                                                           ------         ------          -------       --------

     Income before income taxes                                              31.3           41.9             65.8          164.9

 Provision for income taxes (benefit)                                        12.3           22.8           (286.8)          71.4

 Minority interest in after-tax earnings                                      2.7             .6             54.5           10.6
                                                                           ------         ------          -------       --------

     Income from continuing operations                                       16.3           18.5            298.1           82.9

 Discontinued operations                                                       .2            -                 .4            (.3)
                                                                           ------         ------          -------       --------

     Net income                                                            $ 16.5         $ 18.5          $ 298.5       $   82.6
                                                                           ======         ======          =======       ========

 Basic earnings per share
   Income from continuing operations                                       $  .14         $  .16          $  2.48       $    .70
   Discontinued operations                                                    -              -                -             -
                                                                           ------         ------          -------       -----

     Net income                                                            $  .14         $  .16          $  2.48       $    .70
                                                                           ======         ======          =======       ========

 Diluted earnings per share
   Income from continuing operations                                       $  .14         $  .16          $  2.48       $    .69
   Discontinued operations                                                    -              -                -             -
                                                                           ------         ------          -------       -----

     Net income                                                            $  .14         $  .16          $  2.48       $    .69
                                                                           ======         ======          =======       ========

 Shares used in calculation of per share amounts
   Basic earnings                                                           120.2          117.5            120.2          118.6
                                                                           ======         ======          =======       ========

   Diluted earnings                                                         120.4          117.9            120.4          119.0
                                                                           ======         ======          =======       ========







                          VALHI, INC. AND SUBSIDIARIES

                     RECONCILIATION OF PERCENTAGE CHANGE IN
                       KRONOS' AVERAGE TIO2 SELLING PRICES

                                   (Unaudited)




                                                                            Three months ended           Nine months ended
                                                                              September 30,                September 30,
                                                                              2005 vs. 2004                2005 vs. 2004
                                                                            -----------------            ---------------

Percentage change in average selling prices:
                                                                                                        
  Using actual foreign currency exchange rates                                   +8%                         +12%

  Impact of changes in foreign currency
   exchange rates                                                                -1%                         - 3%
                                                                                 --                          ---

    In billing currencies                                                        +7%                         + 9%
                                                                                 ==                          ===